Abstract
Introduction
The physical disruption of endothelial structure and function due to the formation of an atherosclerotic lesion results in, amongst other factors, a decreased vascular response to agents that stimulate the release of nitric oxide w x from the endothelium 1 . Endothelial dysfunction occurw x ring before the formation of structural disruption 2 is less well-defined and has led to widespread interest in the role ) Ž .
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that lipoproteins may play. It is now clear that responses to endothelium-dependent vasodilators such as acetylcholine Ž . ACh , but not direct smooth muscle dilators such as Ž . sodium nitroprusside SNP , are impaired in forearm resistance vessels of hypercholesterolaemic patients, even w x though these vessels are not prone to atherosclerosis 3,4 . It has been suggested that oxidation of low density lipopro-Ž . teins LDL may play an important role. While in vitro incubation of rabbit aortic rings with non-oxidised LDL has been shown to have no effect on endothelium-depenw x dent relaxation 5,6 , copper-oxidised LDL completely Time for primary review 26 days.
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There is ample evidence that it is the lipid component of LDL that diminishes vascular response to endothelium w x derived nitric oxide 8-10 and further that lysophosphatidylcholine, a substance produced when native LDL are w x oxidised 11 , is responsible. It remains arguable, however, as to the effect of other lipid-carrying lipoproteins such as Ž . high-density lipoprotein HDL and very-low-density Ž . lipoprotein VLDL . While unmodified HDL have been demonstrated to antagonise the vascular effects of oxidised w x LDL 10 , oxidised HDL have also been shown to potently w x inhibit the effects of nitric oxide in their own right 9 . This non-specific inhibitory effect of lipoproteins appears to also extend to unmodified HDL and VLDL obtained w x from rabbit plasma 8 . It is not known whether this is also true of human lipoproteins.
The physiological significance of copper-oxidised lipoproteins is debatable. In the current paper we describe our studies on the effects of unmodified human lipoproteins, LDL, HDL and VLDL, on endothelium-dependent relaxations of the rat isolated aortic ring.
Methods

Preparation of lipoproteins
Approximately 150 ml of blood was taken from normal healthy volunteers. Individual lipoprotein fractions were obtained using discontinuous density gradient ultracentrifu-Ž . gation on a Beckman vertical rotor 70 Ti with a Beckman ultracentrifuge; the VLDL fraction was obtained at 1.006 grml, LDL at 1.063 grml and HDL at 1.21 grml. To concentrate the fraction, VLDL was re-spun at 1.006 grml for a further 18-20 h. The isolated fractions were dialysed for a minimum of 18 h in saline containing EDTA 1 mM. All buffers contained EDTA 1 mM. Free and esterified cholesterol, phospholipids and triglycerides were measured using enzymatic colorimetric methods on a Ž Cobas-Bio centriganalyser Roche Diagnostics, Tegimenta, . Switzerland . Apo A1 and apo B levels were measured using immunoturbidimetric methods on a Cobas-Bio centriganalyser. The protein content of each fraction was determined by a simplified protein assay method of Lowry w x 12 . All lipoprotein fractions were filtered through a 0.45 Ž . m m millex-HV filter unit Millipore MA 01730; Bedford . Fractions were stored for a maximum of 10 days at 48C.
The lipid peroxide content of the lipoprotein samples obtained was monitored fluorometrically as thiobarbituric-Ž .w x acid-reactive substances TBARS 13 ; 300 ml of sample Ž was vortexed with 600 ml of TBARS reagent 15% tri-Ž . chloroacetic acid, 0.375% thiobarbituric acid TBA and . 0.25N HClr100 ml . The samples were centrifuged at 10 000 r.p.m. for 10 min and the supernatant was measured for TBARS using a Cobas-Bio centriganalyser. This was repeated on samples which had been incubated in the organ bath experiments. 
Isolation of rat thoracic aorta
Organ bath experimental protocol
All rings were contracted with a submaximal dose of Ž . noradrenaline NA; 0.1-1 mM . When a steady level of active force was obtained, cumulative concentration-relaxation responses to the endothelium-dependent relaxant Ž . Ž agonists, ACh 1 nM-30 mM and histamine 1 nM-30 . Ž . m M , the calcium ionophore, A23187 1 pM-3 nM and Ž the endothelium-independent vasodilator, SNP 1 nM-30 . mM , were obtained. Only one relaxing agonist was tested on any one aortic ring from any one rat.
Any one of the 3 lipoprotein fractions, VLDL, LDL or HDL, was then added to the organ bath to give a final concentration of either 0.02 or 0.2 mg proteinrml. Lipoproteins obtained from only one individual were tested at any one time. Tissues were left to incubate in the lipoprotein-rich solution for 60 min. In the continued presence of the lipoprotein, cumulative concentration-relaxation curves were repeated with the same agonist as used prior to addition of lipoprotein. At the end of this Ž second curve, rings were thoroughly washed replacement . of fresh Krebs' solution 3-4 times organ bath volume every 10-15 min for 60 min. Cumulative concentrationrelaxation curves were then repeated for the second time. In addition to these single lipoprotein experiments, the Ž . combined effects of HDL 0.2 mg proteinrml and LDL Ž . 0.2 mg proteinrml were also examined. As before, concentration-relaxation response curves to ACh on noradrenaline pre-constricted rat aortic rings were obtained before and in the continued presence, following a 60 min incubation, of LDL and HDL.
Two series of control experiments were performed. The first were time-control experiments, where relaxation responses to ACh were obtained and repeated at the same time points as the experiments described above, but in the absence of any lipoprotein. The second studied the specificity of the effects of the lipoproteins. Thus, relaxationresponse curves to ACh were performed initially and then repeated after a 60 min incubation with bovine serum Ž . albumin 0.2 mg proteinrml .
Data analysis
Individual concentration response curves for each agonist were fitted to a logistic equation of the form:
where E is the response, M is the maximum response, A is the concentration eliciting E, K is the concentration Ž . eliciting 50% of the maximum response i.e., EC and P 50 w x is the slope parameter 14 . The location of the EC value 50 provided a measure of drug potency.
Ž . Data are presented as mean " standard deviation s.d. unless otherwise stated. Results were analysed by analysis Ž . of variance ANOVA followed by Student's unpaired Ž t-test using Sigmastat Statistical Software Jandel Scien-. tific, San Rafael, CA which inherently analyses data for normality prior to performing parametric analysis. Correlations between % inhibition of maximal relaxation of endothelium-dependent agonists by the lipoproteins and cal-Ž culated organ bath concentrations of cholesterol free, . esterified and total , triglycerides and phospholipids were Ž performed using simple regression analysis Sigmastat, . Jandel Scientific, San Rafael, CA . Percent inhibition of maximal relaxation by lipoproteins is defined as the difference in the maximal response obtained to the Ž endothelium-dependent agonist used ACh, histamine, . A23187 in the presence, compared with that obtained in Ž . the absence, of each lipoprotein LDL, VLDL, HDL . Calculated organ bath concentrations of each lipoprotein Ž component free and esterified cholesterol, triglyceride and . phospholipid were grouped into deciles of concentrations and matched against the relevant mean % inhibition. Statistical significance was set at P -0.05. 
Drugs and chemicals
Results
Lipoprotein content
Ž . The mean "standard error of the mean percentage Ž composition free and esterified cholesterol, triglycerides, . phospholipids and protein of LDL, VLDL and HDL are shown in Fig. 1 . As expected, the higher the density of the lipoproteins, the higher the proportion of protein, and the lower the triglyceride concentrations. The levels of malon-Ž . aldehyde MDA reflected the minimally oxidised state of Ž . the lipoproteins Fig. 1 . These levels were not signifi-Ž cantly altered by incubation in the organ baths data not . shown .
Organ bath experiments
Control experiments: time controls and boÕine serum albumin
Time control experiments where concentration-response curves were obtained to ACh at the same time Ž . periods i.e., before and after 1 h , but without any lipoprotein intervention, revealed little effect of time on maximal Ž responses to ACh mean " s.d.: Curve 1, Time 0, 89.0 " . 11.0% vs Curve 2, Time 60 min, 75.6 " 27.1%; P ) 0.05 .
Mean maximum relaxation responses to ACh were not affected after incubation with albumin at 0.2 mg proteinrml Žmean " s.d.: pre-albumin 68.5 " 8.1% vs plus-albumin . 80.8 " 14.0%, P -0.05 . Albumin had no effect on nega-Ž tive log EC values of ACh mean " s.d. pre-albumin 50 . 6.77 " 0.37 vs plus-albumin 6.29 " 0.26 . were significantly attenuated in the presence of LDL 0.2 Ž . mg proteinrml see Table 1 . Maximal relaxation responses to histamine and A23187 were also significantly attenuated. There was no significant shift in the dose-response curves to these agonists. Neither maximal relaxation responses nor potency to SNP were significantly Ž . affected by LDL 0.02 or 0.2 mg proteinrml .
LDL
VLDL
Mean concentration-response curves to ACh in the absence and presence of VLDL 0.02 mg proteinrml are shown in Fig. 2b . Table 2 details the mean maximal responses and potency of all the agonists used in the absence and presence of VLDL. Maximal relaxation mediated by ACh and histamine, but not by A23187, was significantly attenuated in the presence VLDL at 0.02 mg proteinrml. Similarly, EC values to ACh and histamine, 50 but not to A23187 were significantly decreased in the presence of VLDL 0.02 mg proteinrml. On the other hand, maximal relaxation mediated by the 3 endothelium-Ž dependent relaxing agonists used ACh, histamine and 
HDL
Mean concentration-response curves to ACh in the absence and presence of HDL 0.02 mg proteinrml are shown in Fig. 2c . Maximal relaxation responses to ACh, histamine and A23187 were all significantly attenuated in the presence of HDL at 0.02 mg proteinrml and at 0.2 mg Ž . proteinrml Table 3 , but there was no significant change Ž . in the potency of any of these agonists Table 3 .
Ž . Responses to SNP were unaltered by HDL Table 3 .
Combined LDL and HDL
Mean maximum relaxation responses" s.d. mediated by ACh were significantly higher following incubation of Ž LDL combined with HDL pre-lipoproteins 81.8 " 5.7 vs . plus-LDLrHDL 100 " 0.0, P -0.05 . There was no difference in the negative log EC values for ACh after 50 Ž lipoprotein incubation pre-lipoproteins 6.69 " 0.15 vs . plus-LDLrHDL, 6.62 " 0.61 .
Correlations of lipoprotein composition and % maximal inhibition of responses
To investigate whether the inhibition of endotheliumdependent dilatation could be attributed to the composition of the lipoproteins used, correlation analyses were performed comparing the % maximal level of inhibition of all the endothelium-dependent agonists used against the calculated organ bath concentration of each lipoprotein compo-Ž . nent-cholesterol total, free and esterified , triglyceride, . phospholipid; see data, Section 2.4 -regardless of the density at which each fraction was obtained. The calculated organ bath concentration of phospholipids, but not of Ž . cholesterol free, esterified and total or triglycerides, correlated positively with the maximal level of inhibition of relaxation obtained to the endothelium-dependent agonists Ž . r s 0.54, P s 0.01 .
Discussion
The major new finding from the current study is that the inhibitory effect reported of human low-density lipopro-Ž . teins LDL on endothelium-dependent relaxation appears not to be specific to this lipoprotein but is also true of Ž . lipoproteins of high density HDL and very low density Ž . VLDL . We attribute this non-specific action of lipoproteins to the phospholipid composition of each fraction and suggest that it is this component that is responsible for the inhibitory actions of the lipoproteins on endothelium derived relaxation.
Our findings with human lipoproteins are entirely conw x sistent with findings using lipoproteins of rabbit origin 8 . In the previous work, the inhibition observed of ACh-and A23187-mediated dilatation was demonstrated to be lipoprotein phospholipid, but not cholesterol, concentration-dependent. It would also appear from both studies that lipoproteins are capable of potently inhibiting endothelium-dependent dilatation without first having to undergo substantial oxidation as previously suggested. Kugiyama et w x al. 5 found native LDL to have no effect on endothelium-dependent relaxation; however, the concentrations used were half that in the current study and it has been clearly demonstrated that impairment of endothelium-dependent relaxation is concentration-depenw x dent 6 . Organ bath concentrations of LDL used in the current study equate with those observed at physiological plasma levels, those of VLDL are similar to those observed with pathological levels of VLDL and those of HDL somewhat underestimates physiological levels.
We are confident that the non-specific effect of lipoproteins on endothelium-dependent relaxation is not merely a Ž kinetic phenomenon e.g., binding of the compounds to the . protein since tissue incubation with bovine serum albumin had no effect on endothelium-dependent relaxation mediated by ACh. Nor is it due to time-dependent changes in endothelial function as no change in relaxation responses over time was observed.
The inhibitory effect of LDL on endothelial-dependent relaxation has previously been advocated to be contributory to the atherogenic and possibly vaso-spasmogenic actions of this lipoprotein. Following from our data, the corollary would be that both VLDL and HDL are potentially harmful since both these lipoproteins potently inhibit endothelial-dependent relaxation. The latter finding is especially startling since a positive correlation between HDL concentration and ACh-induced relaxation has previously w x been reported in vivo 15 . HDL is also recognised for its anti-atherogenic properties including reverse cholesterol w x transport in vivo 16 and protection of LDL oxidation in w x vitro 17 . To further explore the role of HDL under the current in vitro setting, we studied the combined effect of HDL and LDL. When placed in the organ bath together, endothelium-dependent relaxation to ACh was not impaired, but in fact increased. One explanation may be that the lipoproteins undergo some form of minimal oxidation in the organ bath, which was not detected by the TBARS assay used in the current study, but which is necessary for their inhibitory effect on endothelium-dependent agonists. Co-incubation of HDL with LDL may inhibit this oxidaw x tion as has previously been shown in vitro 17 .
The in vivo effect of VLDL is not known. Since VLDL is the main carrier for triglycerides, our data suggest that pathological levels of VLDL observed in hypertriglyceridaemia would be inhibitory of endothelium-dependent dilatation.
The exact mechanism by which LDL exerts its inhibitory actions on endothelium-dependent relaxation remain unclear. Since the nitric oxide precursor, L-arginine, reverses the endothelium impairment seen in hypercholesw x w x terolaemic rabbits 18 and humans 19 , it may be that w x hypercholesterolaemia depletes L-arginine stores 20 or that LDL blocks binding of nitric oxide synthase enzyme Ž . NOS to L-arginine or that there is increased metabolism of nitric oxide. Other evidence has implicated free radicals sequestering or inactivating NO after it has been released w x from the endothelial cell 9,21,22 . Yet other studies sug- gest that LDL specifically inactivates some part of the G-protein receptor-coupled pathway of bradykinin and ACh w x 23 . As the disease progresses, however, this selective w x receptor inactivation becomes less apparent 24 . Our data using LDL are consistent with the hypothesis that at lower concentrations the effect of LDL appears to be selective, only inhibiting responses to ACh and that this selectivity becomes less apparent at the higher concentration of 0.2 mg proteinrml where inhibition is seen to responses mediated not only by ACh but also by histamine which stimulates synthesis of nitric oxide through phospholipase C w x linked to the G protein 25 , and the receptor-independent q agonist, A23187, which opens calcium channels directly. w x Our data hence support the premise by Flavahan 24 that the mechanism of LDL action is concentration-dependent such that at lower concentrations there is selective inhibition of the G pathway whereas at higher concentrations i the inhibition becomes more global affecting further along the nitric oxide pathway. It is interesting that VLDL appears slightly more potent, inhibiting both ACh and histamine at the concentration of 0.02 mg proteinrml and that HDL is even more potent, inhibiting all 3 endothelium-dependent agonists used at this concentration. This may be entirely dependent on phospholipid content; the design of the current study, however, precludes us from confirming this hypothesis.
In conclusion, we have demonstrated that the in vitro Ž . inhibitory effect of LDL on endothelium nitric oxide -dependent dilatation is not specific to this lipoprotein but is also true of HDL and VLDL. We further conclude that this non-specific action may be attributed to the phospholipid concentration of each fraction.
